Meza-Resillas Jessica, O'Hara Finnegan, Kaushik Syed, Stobart Michael J, Ahmadpour Noushin, Kantroo Meher, Del Rosario John, Rodriguez Megan C, Koval Dmytro, Glück Chaim, Weber Bruno, Stobart Jillian L
College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada; Centre on Aging, University of Manitoba, Winnipeg, Manitoba, Canada.
College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Neurotherapeutics. 2025 Sep;22(5):e00614. doi: 10.1016/j.neurot.2025.e00614. Epub 2025 May 21.
Nimodipine is a L-type voltage gated calcium channel blocker commonly given to patients after a sub-arachnoid hemorrhage. It is known to dilate cerebral arteries and affect brain pericytes that express voltage gated calcium channels. Here, we systemically administered nimodipine (1 mg/kg; i.p.) and measured brain pericyte calcium transients and single-vessel hemodynamics in the brains of mice by two-photon microscopy. We find that nimodipine reduces calcium transients in all types of pericytes, from ensheathing to thin-strand cells, at different locations in the vascular network. This induces local vasodilation of vessels closer to penetrating arterioles but decreases blood cell velocity. These vascular consequences are due to systemic nimodipine effects because direct brain application of nimodipine caused blood cell velocity to increase. Nimodipine treatment also reduced further dilation during neurovascular coupling throughout the vascular network. Overall, this suggests that nimodipine can change cerebrovascular hemodynamics by altering pericyte physiology and these are important considerations for the clinical use of this drug.
尼莫地平是一种L型电压门控钙通道阻滞剂,常用于蛛网膜下腔出血后的患者。已知它可扩张脑动脉,并影响表达电压门控钙通道的脑周细胞。在此,我们通过腹腔注射系统给予小鼠尼莫地平(1毫克/千克),并使用双光子显微镜测量小鼠脑周细胞的钙瞬变和单血管血流动力学。我们发现,尼莫地平可降低血管网络中不同位置的所有类型周细胞(从包绕型到细索型细胞)的钙瞬变。这会导致靠近穿通小动脉的血管局部扩张,但降低血细胞速度。这些血管变化是由于尼莫地平的全身作用,因为直接向脑内应用尼莫地平会使血细胞速度增加。尼莫地平治疗还减少了整个血管网络在神经血管耦合过程中的进一步扩张。总体而言,这表明尼莫地平可通过改变周细胞生理来改变脑血管血流动力学,而这些是该药物临床应用中的重要考虑因素。